Horizons in World Cardiovascular Research
Compartir
Horizons in World Cardiovascular Research. Volume 27
Eleanor H. Bennington (Autor)
·
Nova Medicine and Health
· Tapa Dura
Horizons in World Cardiovascular Research. Volume 27 - Eleanor H. Bennington
Libro Nuevo
Importado
Envío: 10 a 14 días háb.
$ 465.180$ 255.850
Costos de importación incluídos en el precio ✅
Reseña del libro "Horizons in World Cardiovascular Research. Volume 27"
This book focuses on advances in cardiovascular research. Chapter 1 discusses the cardiovascular effects of purslane supplementation as well as the properties, biological effects, and proposed mechanisms of action of purslane and its secondary metabolites. Chapter 2 focuses on reviewing the most significant scientific advancements in current alternative therapies for managing CVDs, emphasizing the bioactive molecules found in herbal and marine plants. Chapter 3 will explore the clinical evidence and a general overview of semaglutide’s role in cardiovascular protection, the mechanism of action, and the implications for the management of patients with cardiovascular risk with the diagnosis of type 2 diabetes. Chapter 4 discusses two new concepts of cardiovascular disease (CVD): “cardiometabolic-based chronic disease (CMBCD)” and “cardiovascular-kidney-metabolic (CKM) syndrome.” Chapter 5 provides an overview of the epidemiology, pathogenesis, and key studies related to AF in athletes. Finally, Chapter 6 discusses the relationship between subclinical carotid atherosclerosis and coronary atherosclerosis in asymptomatic patients without known coronary artery disease.
This book focuses on advances in cardiovascular research. Chapter 1 discusses the cardiovascular effects of purslane supplementation as well as the properties, biological effects, and proposed mechanisms of action of purslane and its secondary metabolites. Chapter 2 focuses on reviewing the most significant scientific advancements in current alternative therapies for managing CVDs, emphasizing the bioactive molecules found in herbal and marine plants. Chapter 3 will explore the clinical evidence and a general overview of semaglutide’s role in cardiovascular protection, the mechanism of action, and the implications for the management of patients with cardiovascular risk with the diagnosis of type 2 diabetes. Chapter 4 discusses two new concepts of cardiovascular disease (CVD): “cardiometabolic-based chronic disease (CMBCD)” and “cardiovascular-kidney-metabolic (CKM) syndrome.” Chapter 5 provides an overview of the epidemiology, pathogenesis, and key studies related to AF in athletes. Finally, Chapter 6 discusses the relationship between subclinical carotid atherosclerosis and coronary atherosclerosis in asymptomatic patients without known coronary artery disease.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
La encuadernación de esta edición es Tapa Dura.
✓ Producto agregado correctamente al carro, Ir a Pagar.
